Recommended Phase II Doses of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma From MonumenTAL-1: Clinical Pharmacology Results
MonumentTAL-1研究中推荐的Talquetamab治疗复发/难治性多发性骨髓瘤患者的II期剂量：临床药理学结果
期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.70004
Gong, Jue; Zhou, Jie; Yuan, Dongfen; Ma, Xuewen; Vishwamitra, Deeksha; Hilder, Brandi; Masterson, Tara J; Tolbert, Jaszianne; Renaud, Thomas; Heuck, Christoph; Kane, Colleen; Samtani, Mahesh N; Girgis, Suzette; Haddish-Berhane, Nahor; Berdeja, Jesus; Krishnan, Amrita; Ouellet, Daniele
